Cutaneous toxicities of antiretroviral therapy for HIV
Autor: | Carrie L. Kovarik, Camille E. Introcaso, Janet Hines |
---|---|
Rok vydání: | 2010 |
Předmět: |
medicine.medical_specialty
biology Reverse-transcriptase inhibitor business.industry Integrase inhibitor Dermatology medicine.disease biology.organism_classification Entry inhibitor Nucleoside Reverse Transcriptase Inhibitor Drug eruption Acquired immunodeficiency syndrome (AIDS) Immunopathology Lentivirus Immunology medicine Protease inhibitor (pharmacology) Lipodystrophy Intensive care medicine Adverse effect business medicine.drug |
Zdroj: | Journal of the American Academy of Dermatology. 63:549-561 |
ISSN: | 0190-9622 |
Popis: | Cutaneous manifestations of antiretroviral medications for HIV are common and potentially dangerous conditions encountered by dermatologists. Part II of this two-part series on the cutaneous effects of antiretroviral medications for HIV will discuss the four most recent classes of medications that have been developed and immune reconstitution syndrome—an important diagnostic consideration when evaluating a dermatologic patient who is taking antiretroviral medications. Learning objectives After completing this learning activity, participants should be able to recognize common and dangerous cutaneous adverse effects related to nonnucleoside reverse transcriptase inhibitors and entry and fusion inhibitors, determine which of these toxicities need further investigation or medication cessation, and understand the dermatologic manifestations of immune reconstitution syndrome and their importance in the differential diagnosis of a drug reaction in HIV-positive patients. |
Databáze: | OpenAIRE |
Externí odkaz: |